SCHEMBL6401065

SCHEMBL6401065

CC1(C)CC(=O)OC1(O)c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA1 P02708 2/20 0.39
CHRNG P07510 2/20 0.39
CHRNB1 P11230 2/20 0.39
CHRNB2 P17787 2/20 0.39
SLC6A2 P23975 2/20 0.39
CHRNB4 P30926 2/20 0.39
SLC6A4 P31645 2/20 0.39
CHRNA3 P32297 2/20 0.39
CHRNA4 P43681 2/20 0.39
SLC6A3 Q01959 2/20 0.39
CHRND Q07001 2/20 0.39
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
DRD2 P14416 1/20 0.35
ALDH1A1 P00352 3/20 0.35
CCR2 P41597 1/20 0.34
HSD11B1 P28845 1/20 0.34
MDM2 Q00987 1/20 0.34
UTS2R Q9UKP6 1/20 0.34
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5183115 0.83 ALDH1A1 (0.44) CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4
SCHEMBL6400054 0.81 CHRNA1 (0.40) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4
SCHEMBL5182491 0.80 NPC1 (0.43) MAPK1KMT2AALDH1A1
SCHEMBL5184259 0.70 CHRNA1 (0.49) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL8115288 0.63 KMT2A (0.40) SLC6A4SLC6A3MAPK1KMT2ADRD2
SCHEMBL11821130 0.62 KMT2A (0.42) SLC6A4SLC6A3MAPK1KMT2AALDH1A1
SCHEMBL6026477 0.61 CHRNA1 (0.39) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL7984729 0.61 CHRNA1 (0.39) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL3279419 0.61 MAPK1 (0.44) SLC6A2SLC6A4SLC6A3MAPK1KMT2A
SCHEMBL17764152 0.61 CCR2 (0.44) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059658-A1 Pyridazinone BAYER AKTIENGESELLSCHAFT (DE) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059658-A1 Pyridazinone TYMP, TPMT, PDXK CHRNA1 3542/4885CHRNG 4280/4885CHRNB1 3972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.